Prescription pattern of anti-Parkinson's disease drugs in Japan based on a nationwide medical claims database.

Suzuki, Masahiko; Arai, Masaki; Hayashi, Ayako; Ogino, Mieko.

Afiliação

Suzuki M; Department of Neurology, The Jikei University Katsushika Medical Center, Tokyo, Japan.
Arai M; Japan Medical Affairs, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Hayashi A; Japan Medical Affairs, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Ogino M; International University of Health and Welfare, School of Medicine, Center for Medical Education, Narita, Japan.

eNeurologicalSci ; 20: 100257, 2020 Sep.

Article em En | MEDLINE | ID: mdl-32775705

Palavras-chave

Anti-Parkinson's disease drug; COMT, catechol-O-methyltransferase; Cross-sectional study; DA, dopamine agonist; DPC/PDPS, Japanese Diagnosis Procedure Combination/Per-Diem Payment System; GPP3, Good Publication Practice 3; Health insurance claims data; ICD-10, International Classification of Disease, Tenth Revision; Japan; L-dopa, levodopa; MAO-B, monoamine oxidase-B; MDV, Medical Data Vision; PD, Parkinson's disease; Parkinson's disease; Prescription pattern

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article